BioVaxys Technology Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 26 Jan 24 | Buy€12,995 | Kenneth Kovan | Individual | 633,333 | €0.021 | |
| 14 Jul 23 | Buy€4,078 | Kenneth Kovan | Individual | 250,000 | €0.017 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 23,780,195 | 10.8% |
| General Public | 196,461,463 | 89.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 48.8%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 16,177,333 | €770.4k | 18.3% | no data | |||
| 7,352,862 | €350.2k | 9.43% | no data | |||
| 250,000 | €11.9k | 0% | no data |